Repository

Publications

Loss of Aquaporin-1 in Tumor Cells Fosters Intrahepatic Cholangiocarcinoma Progression

Gaspari C, Beaupere C, Richard S, Peixoto E, Lekbaby B, Minini M, Dubravcic B, Vaquero J, Vallette M, Arbelaiz A, Janona M, Louis C, Le Gall P, Coulouarn C, Marrone J, Lloréns JA, Marinelli RA, Gradilone SA, Fouassier L
Am J Pathol. 2025 Nov 7:S0002-9440(25)00406-7. doi: 10.1016/j.ajpath.2025.10.007
2025 
Result from  

Epithelial to Mesenchymal Transition Transcriptional Regulator ZEB1 in Liver Cancer: Oncogenic Roles and Therapeutic Potential

Gonzalez-Sanchez E, Roldan-Hernandez CA, Martin-Ramirez A, Garcia-Collado L, Fouassier L, Vaquero J
Int J Mol Sci. 2025 Nov 18;26(22):11135. doi: 10.3390/ijms262211135
2025 
Result from  

Artificial Intelligence-based agents in chronic liver disease: transforming diagnostic and therapeutic workflows through clinical decision-making

Singh Y, Hathaway QA, Vera-Garcia DV, Povero D, Salehi S, Wei Y, Horvat N, Chaudhary A, Mula Kh A, Keishing V, Niazi K, Quaia E, Erickson BJ, Gores GJ, Andersen JB
npj Gut Liver 2, 34 (2025). https://doi.org/10.1038/s44355-025-00049-5
2025 
Result from  
Results from  

Cholangiocarcinoma 2026: status quo, unmet needs and priorities

Banales JM, Rodrigues PM, Affò S, Andersen JB, Aspichueta P, Boulter L, Bridgewater J, Calvisi DF, Cardenas A, Cardinale V, Carpino G, Coulouarn C, Dopazo C, Edeline J, Fabris L, Folseraas T, Forner A, Goeppert B, Heikenwalder M, Kendall TJ, Khan SA, Klümpen HJ, Koerkamp BG, Lamarca A, Lindsey S, Lleo A, Luedde T, Macias RIR, Morement H, Nault JC, Olaizola P, Perugorria MJ, Raggi C, Rimassa L, Saborowski A, Valle JW, Vithayathil M, Vogel A, Braconi C; International CCA Consensus Consortium.
Nat Rev Gastroenterol Hepatol. 2025 Dec 10. doi: 10.1038/s41575-025-01153-w
2026 
Result from  

Opportunities and Approaches to Optimising Advanced Cholangiocarcinoma Outcomes in the Era of Targeted Therapies: A Narrative Review

Macarulla T, Neuzillet C, Prager GW, Rimassa L, Bridgewater J
Oncol Ther. 2025 Dec;13(4):939-962. doi: 10.1007/s40487-025-00370-2
2025 
Result from  
Join the Action
JOIN